Department of Oral and Maxillofacial Surgery, The affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Department of Dental Digital Medicine and 3D Printing Engineering Laboratory, Qingdao University, Qingdao, Shandong, China.
Bioengineered. 2020 Dec;11(1):91-102. doi: 10.1080/21655979.2019.1710925.
Numerous findings have demonstrated that MicroRNAs dysregulation plays a key role in many neoplasms, including oral squamous cell carcinoma (OSCC), yet the potential mechanisms of microRNAs in chemo-resistance remain elusive. Here, we analyzed the miR-132 expression in OSCC tissues and OSCC cell lines, and explored it role and mechanisms on invasion and migration and cisplatin (CDDP)-induced cell death. The clinical tissues of 37 patients with OSCCs and paired normal tissues were collected. The miR-132 expression in OSCC tissues and cell lines were detected by reverse transcription-quantitative polymerase chain reation (RT-qPCR). The repopulation models were established to mimic the biological processes of OSCC. The results showed that miR-132 expression was significantly decreased in the OSCC tissues and CDDP resistant OSCC cell line (CAL-27/CDDP). miR-132 mimic inhibited cell proliferation, invasion, migration and enhanced the pro-apoptotic ability of CDDP. On the contrary, downregulation of miR-132 promoted proliferation, invasion, migration and conferred OSCC cell resistance to CDDP-induced apoptosis . The TGF-β1 expression in OSCC tissues and CAL-27/CDDP cells was significantly higher. miR-132 significantly inhibited the TGF-β1/Smad2/3 signals. TGF-β1 upregulation significantly promoted OSCC cell proliferation and resumed OSCC cell chemo-resistance in the miR-132 overexpressing cells, which is contrary to the function of miR-132. In summary, miR-132 acts as a tumor suppressor and exerts a substantial role in inhibiting the proliferation, invasion, and enhanced the chemosensitivity to CDDP of OSCC via regulating TGF-β1/Smad2/3 signals . These observations indicate that miR-132 may be a suitable therapeutic target for the treatment of OSCC.
大量研究结果表明,MicroRNAs 失调在许多肿瘤中发挥关键作用,包括口腔鳞状细胞癌(OSCC),但 microRNAs 在化疗耐药中的潜在机制仍不清楚。在这里,我们分析了 OSCC 组织和 OSCC 细胞系中的 miR-132 表达,并探讨了其在侵袭和迁移以及顺铂(CDDP)诱导的细胞死亡中的作用和机制。收集了 37 例 OSCC 患者的临床组织和配对正常组织。通过逆转录-定量聚合酶链反应(RT-qPCR)检测 OSCC 组织和细胞系中的 miR-132 表达。建立再群体模型以模拟 OSCC 的生物学过程。结果表明,miR-132 在 OSCC 组织和 CDDP 耐药 OSCC 细胞系(CAL-27/CDDP)中的表达明显降低。miR-132 模拟物抑制细胞增殖、侵袭、迁移并增强 CDDP 的促凋亡能力。相反,下调 miR-132 促进了增殖、侵袭、迁移,并赋予 OSCC 细胞对 CDDP 诱导的凋亡的耐药性。OSCC 组织和 CAL-27/CDDP 细胞中的 TGF-β1 表达明显升高。miR-132 显著抑制 TGF-β1/Smad2/3 信号。TGF-β1 的上调显著促进了 miR-132 过表达细胞中 OSCC 细胞的增殖,并恢复了 OSCC 细胞对化疗的耐药性,这与 miR-132 的功能相反。总之,miR-132 作为一种肿瘤抑制因子,通过调节 TGF-β1/Smad2/3 信号,在抑制 OSCC 的增殖、侵袭和增强对 CDDP 的化疗敏感性方面发挥重要作用。这些观察结果表明,miR-132 可能是治疗 OSCC 的合适治疗靶点。